Edition:
United Kingdom

People: Idorsia Ltd (IDIA.S)

IDIA.S on Swiss Exchange

23.30CHF
16 Aug 2019
Change (% chg)

CHF0.80 (+3.56%)
Prev Close
CHF22.50
Open
CHF22.54
Day's High
CHF23.32
Day's Low
CHF22.52
Volume
502,071
Avg. Vol
321,011
52-wk High
CHF25.02
52-wk Low
CHF15.20

Garnier, Jean-Pierre 

Dr. Jean-Pierre (JP) Garnier, Ph.D., is Non-Executive Independent Chairman of the Board of Idorsia Ltd. He holds Various management positions at ScheringPlough. Within SmithKline Beecham, President of the pharmaceutical business in North America (1990), elected to the Board of Directors (1992), Chairman, Pharmaceuticals (from 1994), Chief Operating Officer (COO) (from 1995) and Chief Executive Officer (CEO) (from April 2000). First CEO of GlaxoSmithKline, 2001–2008. CEO of Laboratoires Pierre Fabre, 2008–2010. He is a Member of the Board of Directors of three listed companies, United Technologies Corporation, Radius Health, Inc., Carmat SA (Chairman) and former Chairman of one unlisted company, Alzheon, Inc. (until August 2018). Operating Partner of the unlisted company Advent International Corporation. Member of the Advisory Board of Newman’s Own Foundation. Officer of the Legion of Honour and Knight Commander of the Order of the British Empire. He holds MSc in Pharmaceutical Science and PhD in Pharmacology from Louis Pasteur University, Strasbourg, France; MBA from Stanford University, California, US.

Basic Compensation

Total Annual Compensation, CHF 65,625
Restricted Stock Award, CHF --
Long-Term Incentive Plans, CHF --
All Other, CHF 190,954
Fiscal Year Total, CHF 256,579

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --